Cargando…
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
Epigenetic dysregulation plays a pivotal role in mixed-lineage leukemia (MLL) pathogenesis, therefore serving as a suitable therapeutic target. S-adenosylmethionine (SAM) is the universal methyl donor in human cells and is synthesized by methionine adenosyltransferase 2A (MAT2A), which is deregulate...
Autores principales: | Secker, Kathy-Ann, Bloechl, Bianca, Keppeler, Hildegard, Duerr-Stoerzer, Silke, Schmid, Hannes, Schneidawind, Dominik, Jeong, Johan, Hentrich, Thomas, Schulze-Hentrich, Julia M., Schneidawind, Corina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281730/ https://www.ncbi.nlm.nih.gov/pubmed/32456310 http://dx.doi.org/10.3390/cancers12051342 |
Ejemplares similares
-
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
por: Fitzel, Rahel, et al.
Publicado: (2023) -
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations
por: Secker, Kathy-Ann, et al.
Publicado: (2020) -
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018) -
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells
por: Schmid, Hannes, et al.
Publicado: (2021) -
Inhibition of effector B cells by ibrutinib in systemic sclerosis
por: Einhaus, Jakob, et al.
Publicado: (2020)